2190 — Zylox-Tonbridge Medical Technology Co Balance Sheet
0.000.00%
HealthcareHighly SpeculativeMid CapSucker Stock
- HK$6.74bn
- HK$3.35bn
- CNY177.91m
Annual balance sheet for Zylox-Tonbridge Medical Technology Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | |
---|---|---|---|
Period Length: | — | — | — |
Source: | PROSPECTUS | PROSPECTUS | ARS |
Standards: | IFRS | IFRS | IFRS |
Status: | Final | Final | Final |
Cash | |||
Short Term Investments | |||
Cash and Short Term Investments | 98.1 | 317 | 2,929 |
Net Total Accounts Receivable | |||
Net Total Receivables | 8.74 | 6.5 | 5.33 |
Total Inventory | |||
Prepaid Expenses | |||
Total Other Current Assets | |||
Total Current Assets | 125 | 370 | 3,024 |
Gross Property, Plant And Equipment | |||
Accumulated Depreciation | |||
Net Property, Plant And Equipment | 70.7 | 122 | 212 |
Net Intangible Assets | |||
Other Long Term Assets | |||
Total Assets | 207 | 504 | 3,248 |
Accounts Payable | |||
Accrued Expenses | |||
Notes Payable / Short Term Debt | |||
Current Portion of Long Term Debt / Capital Leases | |||
Total Other Current Liabilities | |||
Total Current Liabilities | 33.4 | 51.6 | 97.1 |
Long Term Debt | |||
Capital Lease Obligations | |||
Total Long Term Debt | |||
Total Debt | |||
Total Liabilities | 41.4 | 79.3 | 104 |
Common Stock | |||
Additional Paid In Capital | |||
Retained Earnings (Accumulated Deficit) | |||
Treasury Stock | |||
ESOP Debt Guarantee | |||
Other Equity | |||
Total Equity | 166 | 425 | 3,145 |
Total Liabilities & Shareholders' Equity | 207 | 504 | 3,248 |
Total Common Shares Outstanding |